Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

byBenzinga Newsdesk

January 17, 2023

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.

Analyst Ratings

A Closer Look at 10 Analyst Recommendations For UDR

By Benzinga Insights

April 25, 11:00 AM

Ratings for UDR (NYSE:UDR) were provided by 10 analysts in the past three months, showcasing a mix of…

UDR

AudioEye Q2 EPS $(0.23) Beats $(0.32) Estimate, Sales $7.57M Beat $7.51M Estimate

By Michael Horton

August 9, 4:04 PM

AudioEye (NASDAQ:AEYE) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.32) by 28.13 percent. This is a 76.92 percent decrease over losses of $(0.13) per share from the same

AEYE

News

Why Sunrun Shares Are Rising

By Henry Khederian

August 30, 10:32 AM

Sunrun Inc (NASDAQ: RUN) shares are trading higher by 3.7% to $15.72 Wednesday morning after Citigroup upgraded the stock from Neutral to Buy.

RUN

Why Smart For Life Stock Is Down Today

By Ryan Gustafson

May 30, 2:44 PM

Smart for Life, Inc. (NASDAQ: SMFL) shares are trading lower on Tuesday afternoon after the company announced an agreement to exercise warrants for $4.5 million in gross proceeds.

SMFL

HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral

Related Posts

A Closer Look at 10 Analyst Recommendations For UDR

AudioEye Q2 EPS $(0.23) Beats $(0.32) Estimate, Sales $7.57M Beat $7.51M Estimate

Why Sunrun Shares Are Rising

Why Smart For Life Stock Is Down Today